Heterogeneity in colorectal cancer incidence among people recommended three-yearly surveillance post-polypectomy: a validation study
File(s)a-1217-0155.pdf (872.31 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Background
Colonoscopy surveillance is recommended for patients at increased risk of colorectal cancer (CRC) following adenoma removal. Low-, intermediate-, and high-risk groups are defined by baseline adenoma characteristics. We previously evaluated surveillance in intermediate-risk patients using UK hospital data, identifying a higher-risk subgroup who benefitted from surveillance and a lower-risk subgroup who may not require surveillance. Here we explored whether these findings apply in individuals undergoing CRC screening.
Methods
Retrospective study using data from the UK Flexible Sigmoidoscopy Screening Trial (UKFSST), English CRC screening pilot (ECP), and US Kaiser Permanente CRC prevention programme (KPCP). Screening participants aged 50–74 years and classed as intermediate-risk at baseline colonoscopy were included. CRC data were available through 2006 (KPCP) or 2014 (UKFSST, ECP). We classified participants into lower- and higher-risk subgroups using our previously identified baseline risk factors; higher-risk participants were those with incomplete colonoscopies, poor bowel preparation, adenomas ≥20mm or with high-grade dysplasia, or proximal polyps. We compared CRC incidence rates in these subgroups and in the presence versus absence of surveillance using Cox regression.
Results
Of 2291 intermediate-risk participants, 45% were classified as higher-risk. Median follow-up was 11.8 years. CRC incidence rates were significantly higher in the higher-risk than lower-risk subgroup (hazard ratio [HR]=2.08, 95%CI 1.07–4.06). Surveillance reduced CRC incidence rates in higher-risk participants (HR=0.35, 0.14–0.86), but not statistically significantly so in lower-risk participants (HR=0.41, 0.12–1.38).
Conclusion
As previously demonstrated for hospital patients, screening participants classed as intermediate-risk comprise two risk subgroups. Surveillance clearly benefits the higher-risk subgroup.
Colonoscopy surveillance is recommended for patients at increased risk of colorectal cancer (CRC) following adenoma removal. Low-, intermediate-, and high-risk groups are defined by baseline adenoma characteristics. We previously evaluated surveillance in intermediate-risk patients using UK hospital data, identifying a higher-risk subgroup who benefitted from surveillance and a lower-risk subgroup who may not require surveillance. Here we explored whether these findings apply in individuals undergoing CRC screening.
Methods
Retrospective study using data from the UK Flexible Sigmoidoscopy Screening Trial (UKFSST), English CRC screening pilot (ECP), and US Kaiser Permanente CRC prevention programme (KPCP). Screening participants aged 50–74 years and classed as intermediate-risk at baseline colonoscopy were included. CRC data were available through 2006 (KPCP) or 2014 (UKFSST, ECP). We classified participants into lower- and higher-risk subgroups using our previously identified baseline risk factors; higher-risk participants were those with incomplete colonoscopies, poor bowel preparation, adenomas ≥20mm or with high-grade dysplasia, or proximal polyps. We compared CRC incidence rates in these subgroups and in the presence versus absence of surveillance using Cox regression.
Results
Of 2291 intermediate-risk participants, 45% were classified as higher-risk. Median follow-up was 11.8 years. CRC incidence rates were significantly higher in the higher-risk than lower-risk subgroup (hazard ratio [HR]=2.08, 95%CI 1.07–4.06). Surveillance reduced CRC incidence rates in higher-risk participants (HR=0.35, 0.14–0.86), but not statistically significantly so in lower-risk participants (HR=0.41, 0.12–1.38).
Conclusion
As previously demonstrated for hospital patients, screening participants classed as intermediate-risk comprise two risk subgroups. Surveillance clearly benefits the higher-risk subgroup.
Date Issued
2020-11-09
Date Acceptance
2020-06-12
Citation
Endoscopy, 2020, 53 (04), pp.402-410
ISSN
0013-726X
Publisher
Thieme Publishing
Start Page
402
End Page
410
Journal / Book Title
Endoscopy
Volume
53
Issue
04
Copyright Statement
© 2020. The Author(s).This is an open access article published by Thieme under the terms of the CreativeCommons Attribution-NonDerivative-NonCommercial License, permitting copyingand reproduction so long as the original work is given appropriate credit. Contentsmay not be used for commecial purposes, or adapted, remixed, transformed orbuilt upon. (https://creativecommons.org/licenses/by-nc-nd/4.0)
Sponsor
Cancer Research UK
National Institute for Health Research
Cancer Research UK
Grant Number
16894
HTA 16/65/01
25004
Subjects
Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
Surgery
COLONOSCOPY SURVEILLANCE
ADENOMA CHARACTERISTICS
FOLLOW-UP
SIGMOIDOSCOPY
GUIDELINES
RECURRENCE
SOCIETY
REMOVAL
Gastroenterology & Hepatology
1103 Clinical Sciences
Publication Status
Published
Date Publish Online
2020-08-19